Patents by Inventor Aslihan Akkar

Aslihan Akkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising cyclosporin
    Patent number: 9724382
    Abstract: The invention relates to liquid pharmaceutical compositions containing: a) a therapeutically effective dose of a cyclosporin; b) an aqueous carrier liquid; c) a first solubilizing substance selected among the group of phospholipids; and d) a second solubilizing substance selected among the group of non-ionic surfactants. Preferably, the cyclosporin is liposome solubilized. The inventive composition is suitable for oral, parenteral, nasal, mucosal, topical, and particularly pulmonary application in the form of an aerosol.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: August 8, 2017
    Assignee: PARI Pharma GMBH
    Inventors: Manfred Keller, Aslihan Akkar, Ralf Mehrwald
  • Pharmaceutical compositions comprising cyclosporin
    Patent number: 9161963
    Abstract: The invention relates to liquid pharmaceutical compositions containing: a) a therapeutically effective dose of a cyclosporin; b) an aqueous carrier liquid; c) a first solubilizing substance selected among the group of phospholipids; and d) a second solubilizing substance selected among the group of non-ionic surfactants. Preferably, the cyclosporin is liposome solubilized. The inventive composition is suitable for oral, parenteral, nasal, mucosal, topical, and particularly pulmonary application in the form of an aerosol.
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: October 20, 2015
    Assignee: Pari Pharma GMBH
    Inventors: Manfred Keller, Aslihan Akkar, Ralf Mehrwald
  • Pharmaceutical Compositions Comprising Cyclosporin
    Publication number: 20090169607
    Abstract: The invention relates to liquid pharmaceutical compositions containing: a) a therapeutically effective dose of a cyclosporin; b) an aqueous carrier liquid; c) a first solubilizing substance selected among the group of phospholipids; and d) a second solubilizing substance selected among the group of non-ionic surfactants. Preferably, the cyclosporin is liposome solubilized. The inventive composition is suitable for oral, parenteral, nasal, mucosal, topical, and particularly pulmonary application in the form of an aerosol.
    Type: Application
    Filed: November 29, 2006
    Publication date: July 2, 2009
    Applicant: PARI PHARMA GMBH
    Inventors: Manfred Keller, Aslihan Akkar
  • Nebulised Antibiotics for Inhalation Therapy
    Publication number: 20090025713
    Abstract: The present invention provides pharmaceutical aerosols which are useful for the prevention or treatment of infectious diseases of the airways, such as the lungs, the bronchi, or the sinunasal cavities. The aerosols comprise an active agent selected from the group of quinolone antibiotics. Also disclosed are liquid and solid compositions suitable for being converted into the aerosols, and kits comprising such compositions.
    Type: Application
    Filed: February 8, 2007
    Publication date: January 29, 2009
    Applicant: PARI Pharma GmbH
    Inventors: Manfred Keller, Aslihan Akkar